Table 1.

Overview of samples included in the schizophrenia case versus control analysis. LNDBB = MRC London Neurodegenerative Diseases Brain Bank, DBCBB = Douglas-Bell Canada Brain Bank.

			N	Sex (male:female)	Age at death	Brain weight (g)	pH
LNDBB	Prefrontal cortex	schizophrenia	20	11:9	62.05 ± 15.87	1232.94 ± 129.22	6.64 ± 0.28
		controls	23	17:6	62.04 ± 18.74	1368.48 ± 185.22	6.49 ± 0.33
		total	43	28:15	62.05 ± 17.26	1310.88 ± 175.52	6.56 ± 0.31
		P	–	–	1.00	0.01	0.13
	Striatum	schizophrenia	21	11:10	61.76 ± 16.61	1227.44 ± 123.68	6.60 ± 0.30
		controls	28	20:8	63.43 ± 18.16	1360.52 ± 184.59	6.46 ± 0.33
		total	49	31:18	62.71 ± 17.36	1302.10 ± 172.37	6.53 ± 0.32
		P	–	–	0.74	0.01	0.17
	Hippocampus	schizophrenia	14	10:4	60.71 ± 15.93	1271.25 ± 139.22	6.63 ± 0.28
		controls	13	11:2	61.92 ± 17.80	1415.27 ± 173.82	6.48 ± 0.41
		total	27	21:6	61.30 ± 16.54	1340.13 ± 169.81	6.56 ± 0.34
		P	–	–	0.85	0.04	0.31
	Cerebellum	schizophrenia	21	11:10	61.76 ± 16.61	1227.44 ± 123.68	6.60 ± 0.30
		controls	23	17:6	61.39 ± 19.25	1361.30 ± 185.03	6.46 ± 0.33
		total	44	28:16	61.57 ± 17.83	1232.41 ± 172.79	6.60 ± 0.32
		P	–	–	0.95	0.01	0.15
DBCBB	Prefrontal cortex	schizophrenia	18	15:3	45.50 ± 16.61	1431.78 ± 188.16	6.23 ± 0.22
		controls	15	13:2	42.27 ± 14.80	1462.96 ± 175.17	6.12 ± 0.32
		total	33	28:5	44.03 ± 15.65	1447.37 ± 179.32	6.18 ± 0.27
		P	–	–	0.56	0.64	0.27
	Striatum	schizophrenia	16	13:3	46.25 ± 17.10	1410.90 ± 193.35	6.21 ± 0.22
		controls	17	14:3	45.65 ± 16.82	1438.02 ± 180.91	6.09 ± 0.31
		total	33	27:6	45.94 ± 16.69	1426.27 ± 183.61	6.15 ± 0.27
		P	–	–	0.92	0.70	0.23
	Cerebellum	schizophrenia	16	14:2	44.56 ± 15.84	1404.62 ± 161.90	6.25 ± 0.22
		controls	17	14:3	45.65 ± 16.82	1438.02 ± 180.91	6.09 ± 0.31
		total	33	28:5	45.12 ± 16.10	1422.94 ± 170.58	6.17 ± 0.28
		P	–	–	0.85	0.59	0.10